Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in ulcerative colitis and Crohn's disease
NCT04883840Phase 3Terminated
- Sponsor
- UZ Leuven
- Start
- Oct 2020
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in ulcerative colitis (UC), Crohn's disease, sponsored by UZ Leuven. Started Oct 2020; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
ulcerative colitis (UC)Crohn's disease
Beyond the preview
Go deeper on NCT04883840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04883840.